Tenaya Therapeutics (TNYA) Cash & Equivalents (2020 - 2026)
Tenaya Therapeutics (TNYA) reported Cash & Equivalents of $66.8 million for Q3 2026, up 18.6% from $56.31 million a year earlier but down 14.5% from the prior quarter.
Tenaya Therapeutics (TNYA) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Tenaya Therapeutics posted Cash & Equivalents of $100.55 million.
- Cash & Equivalents has a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $4.32 million in FY2024 (-90.5%), $45.68 million in FY2023 (-52.1%), $95.27 million in FY2022 (+149.9%) and $38.13 million in FY2021 (-70.3%).
- Five-year quarterly Cash & Equivalents spans a low of $4.32 million in Q4 2024 and a high of $100.55 million in Q4 2025.
- Year over year, Cash & Equivalents has now increased in each of the last three quarters, with growth averaging 83.7% over the last seven quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2025 (growth of 584.1%); the low point was Q4 2024 (a decline of 90.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $78.09 million (Q2 2026), $80.89 million (Q1 2026) and $100.55 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Tenaya Therapeutics | 84.33 Mn | 17.53 Mn | - | 66.80 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 66.80 Mn |
| Jun 30, 2026 | 78.09 Mn |
| Mar 31, 2026 | 80.89 Mn |
| Dec 31, 2025 | 100.55 Mn |
| Sep 30, 2025 | 56.31 Mn |
| Jun 30, 2025 | 62.67 Mn |
| Mar 31, 2025 | 53.77 Mn |
| Dec 31, 2024 | 4.32 Mn |
| Sep 30, 2024 | 8.23 Mn |
| Jun 30, 2024 | 58.13 Mn |
| Mar 31, 2024 | 59.30 Mn |
| Dec 31, 2023 | 45.68 Mn |
| Sep 30, 2023 | 82.15 Mn |
| Jun 30, 2023 | 75.57 Mn |
| Mar 31, 2023 | 72.54 Mn |
| Dec 31, 2022 | 95.27 Mn |
| Sep 30, 2022 | 34.49 Mn |
| Jun 30, 2022 | 31.01 Mn |
| Mar 31, 2022 | 25.97 Mn |
| Dec 31, 2021 | 38.13 Mn |
Tenaya Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TNYA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TNYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TNYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();